NL-OMON27030
Other
Not Applicable
Addition of stereotactic radiotherapy to the standard FOLFIRINOX treatment in locally advanced pancreatic cancer patients to determine efficacy and feasibility.
Foundation for Liver and Gastrointestinal Research0 sites51 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- locally advanced pancreatic cancerpancreatic neoplasmFOLFIRINOXstereotactic radiotherapy
- Sponsor
- Foundation for Liver and Gastrointestinal Research
- Enrollment
- 51
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cytological or histologically confirmation of pancreatic cancer.
- •\-WHO performance status of 0 or 1
Exclusion Criteria
- •\-Prior radiotherapy, chemotherapy or resection (bypass surgery allowed).
- •\-Lymph node metastases from primary tumor outside the field of radiation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Addition of stereotactic radiotherapy to the standard FOLFIRINOX treatment in locally advanced pancreatic cancer patients to determine efficacy and feasability (LAPC-1)locally advanced pancreatic carcinomaPancreatic cancer1001567410017991NL-OMON44466Stichting Leveronderzoek51
Active, not recruiting
Phase 1
Addition of stereotactic body radiotherapy (SBRT) to chemotherapy in locally advanced biliary tract cancersocally advanced biliary tract cancerMedDRA version: 21.0Level: LLTClassification code 10004586Term: Bile duct adenocarcinoma non-resectableSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10008594Term: Cholangiocarcinoma non-resectableSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-003656-31-GBniversity College London81
Active, not recruiting
Not Applicable
A trial looking at whether stereotactic radiotherapy together with chemotherapy is a useful treatment for people with locally advanced bile duct cancer (ABC-07)Biliary tract cancerCancerMalignant neoplasm of other and unspecified parts of biliary tractISRCTN10639376niversity College London83
Active, not recruiting
Not Applicable
Stereotactic accelerated radiotherapy concurrent with Temozolomide chemotherapy in newly diagnosed glioblastoma - NDEUCTR2009-015614-21-ITISTITUTO NEUROLOGICO CARLO BESTA
Recruiting
Not Applicable
Stereotactic Body Radiotherapy for the Management of Prostate Cancer Local RecurrencesC61Malignant neoplasm of prostateDRKS00030837Europäisches Radiochirurgie Centrum München50